SCHEMBL2099259

SCHEMBL2099259

CCN(C)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14707175 0.80 MEN1 (0.42)
SCHEMBL3478490 0.79
SCHEMBL28177679 0.79
SCHEMBL11990754 0.79 MEN1 (0.39)
SCHEMBL12446699 0.78
SCHEMBL3328956 0.78
SCHEMBL11841194 0.77 BCHE (0.30)
SCHEMBL8888937 0.76
SCHEMBL437808 0.76
SCHEMBL19883438 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110951310-B Use of carbamates as organic solvents 万华化学(北京)有限公司 2022-07-12 CN claimed
CN-110951310-A Use of carbamates as organic solvents 万华化学(北京)有限公司 2020-04-03 CN claimed
EP-1838712-B8 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2011-10-12 EP claimed
CN-101124228-A Pyrazolopyrimidine compounds as antitumor agents ASTRAZENECA AB (SE) 2008-02-13 CN claimed
EP-1838712-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2007-10-03 EP claimed
JP-2007505874-A 2007-03-15 JP claimed
US-20070015743-A1 Quinazoline derivatives as antitumor agents ASTRAZENECA AB (SE) 2007-01-18 US claimed
CN-1882572-A Quinazoline derivatives as antitumor agents ASTRAZENECA AB (SE) 2006-12-20 CN claimed
WO-2006064196-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2006-06-22 WO claimed
EP-1664029-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2006-06-07 EP claimed
WO-2005026152-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2005-03-24 WO claimed
US-20250011334-A1 FUSED TRICYCLIC PYRIDAZINONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2025-01-09 US disclosed
US-20230140949-A1 METHOD FOR THE SYNTHESIS OF ISOCYANATES TECHNISCHE UNIVERSITÄT BERGAKADEMIE FREIBERG (DE) 2023-05-11 US disclosed
CN-115701977-A Composition for treating hair or fiber comprising alkylketene compound 株式会社LG生活健康 2023-02-14 CN disclosed
US-20230037883-A1 ALKENE-CONTAINING AMIDE COMPOUND AND APPLICATION THEREOF JIANGSU YANGNONG CHEMICAL CO., LTD (CN) 2023-02-09 US disclosed
WO-2004093880-A1 4-ANILINO-QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS ASTRAZENECA AB (SE) 2004-11-04 WO disclosed
US-4664851-A CATALYTIC HOMOLOGATION SHELL OIL COMPANY (US) 1987-05-12 US disclosed
EP-0085204-B1 PROCESS FOR THE CO-PRODUCTION OF CARBOXYLIC ACIDS AND CARBOXYLIC ACID ESTERS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1986-02-12 EP disclosed
EP-0134601-A2 Process for the preparation of carboxylic acids SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-03-20 EP disclosed
EP-0085204-A1 Process for the co-production of carboxylic acids and carboxylic acid esters SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1983-08-10 EP disclosed